Mark M Mitsnefes
Overview
Explore the profile of Mark M Mitsnefes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
3126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ebrahimi M, Hooper S, Mitsnefes M, Vasan R, Kimmel P, Warady B, et al.
Pediatr Nephrol
. 2025 Jan;
PMID: 39820505
Background: The gut-kidney axis is implicated in chronic kidney disease (CKD) morbidity. We describe how a panel of gut microbiome-derived toxins relates to kidney function and neurocognitive outcomes in children...
2.
Li L, Zhou T, Lu Y, Chen J, Lei Y, Wu Q, et al.
medRxiv
. 2024 Jul;
PMID: 38978683
We investigated the risks of post-acute and chronic adverse kidney outcomes of SARS-CoV-2 infection in the pediatric population via a retrospective cohort study using data from the RECOVER program. We...
3.
Shah S, Christianson A, Meganathan K, Leonard A, Crews D, Rubinstein J, et al.
J Am Heart Assoc
. 2024 May;
13(9):e029691.
PMID: 38700013
Background: Cardiovascular disease is the leading cause of mortality in patients with kidney failure, and their risk of cardiovascular events is 10 to 20 times higher as compared with the...
4.
Nehus E, Sheanon N, Zhang W, Marcovina S, Setchell K, Mitsnefes M
Pediatr Nephrol
. 2024 Jan;
39(6):1875-1883.
PMID: 38172468
Background: This study evaluated urinary sphingolipids as a marker of diabetic kidney disease (DKD) in adolescents and young adults with youth-onset type 1 and type 2 diabetes. Methods: A comprehensive...
5.
Mitsnefes M, Maltenfort M, Denburg M, Flynn J, Schuchard J, Dixon B, et al.
EBioMedicine
. 2023 Nov;
98:104885.
PMID: 37988770
Background: Identification of abnormal blood pressure (BP) in children requires normative data. We sought to examine the feasibility of using "real-world" office BP data obtained from electronic health records (EHR)...
6.
Jiang K, Greenberg J, Abraham A, Xu Y, Schelling J, Feldman H, et al.
Kidney360
. 2023 Jun;
4(8):1039-1047.
PMID: 37303083
No abstract available.
7.
Hamdani G, Mitsnefes M
Curr Hypertens Rep
. 2023 Mar;
25(5):51-60.
PMID: 36862274
Purpose Of Review: To review the current literature regarding hypertension (HTN) following pediatric solid organ transplant (SOTx), including definition, prevalence, risk factors, outcomes, and treatment. Recent Findings: In recent years...
8.
Mitsnefes M, Wuhl E
Pediatr Nephrol
. 2023 Feb;
38(11):3519-3528.
PMID: 36732375
Hypertension is frequent in children with chronic kidney disease (CKD). Its prevalence varies according to CKD stage and cause. It is relatively uncommon in children with congenital kidney disease, while...
9.
Warady B, Feldman D, Bell L, Bacchetta J, Denburg M, Flynn J, et al.
Am J Kidney Dis
. 2022 Nov;
81(4):466-474.
PMID: 36410592
Development of clinical guidelines and recommendations to address the care of pediatric patients with chronic kidney disease (CKD) has rarely included the perspectives of providers from a variety of health...
10.
Kogon A, Roem J, Schneider M, Mitsnefes M, Zemel B, Warady B, et al.
Pediatr Nephrol
. 2022 Aug;
38(4):1257-1266.
PMID: 36018433
Background: Obesity is prevalent among children with chronic kidney disease (CKD) and is associated with cardiovascular disease and reduced quality of life. Its relationship with pediatric CKD progression has not...